Systematic Review of Safety of Selective Androgen Receptor Modulators in Healthy Adults: Implications for Recreational Users
Selective Androgen Receptor Modulators (SARMs) are not FDA approved, and obtaining SARMs for personal use is illegal. Nevertheless, SARM use is increasingly popular amongst recreational athletes. Recent case reports of drug-induced liver injury (DILI) and tendon rupture raise serious concerns for th...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Journal of Xenobiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2039-4713/13/2/17 |
_version_ | 1797593901569146880 |
---|---|
author | Jonathan D. Vignali Kevin C. Pak Holly R. Beverley Jesse P. DeLuca John W. Downs Adrian T. Kress Brett W. Sadowski Daniel J. Selig |
author_facet | Jonathan D. Vignali Kevin C. Pak Holly R. Beverley Jesse P. DeLuca John W. Downs Adrian T. Kress Brett W. Sadowski Daniel J. Selig |
author_sort | Jonathan D. Vignali |
collection | DOAJ |
description | Selective Androgen Receptor Modulators (SARMs) are not FDA approved, and obtaining SARMs for personal use is illegal. Nevertheless, SARM use is increasingly popular amongst recreational athletes. Recent case reports of drug-induced liver injury (DILI) and tendon rupture raise serious concerns for the safety of recreational SARM users. On 10 November 2022 PubMed, Scopus, Web of Science, and ClinicalTrials.gov were searched for studies that reported safety data of SARMs. A multi-tiered screening approach was utilized, and any study or case report of generally healthy individuals exposed to any SARM was included. Thirty-three studies were included in the review with 15 case reports or case series and 18 clinical trials (total patients N = 2136 patients, exposed to SARM N = 1447). There were case reports of drug-induced liver injury (DILI) (N = 15), Achilles tendon rupture (N = 1), rhabdomyolysis (N = 1), and mild reversible liver enzyme elevation (N = 1). Elevated alanine aminotransferase (ALT) was commonly reported in clinical trials in patients exposed to SARM (mean 7.1% across trials). Two individuals exposed to GSK2881078 in a clinical trial were reported to have rhabdomyolysis. Recreational SARM use should be strongly discouraged, and the risks of DILI, rhabdomyolysis, and tendon rupture should be emphasized. However, despite warnings, if a patient refuses to discontinue SARM use, ALT monitoring or dose reduction may improve early detection and prevention of DILI. |
first_indexed | 2024-03-11T02:16:05Z |
format | Article |
id | doaj.art-170c10edb2494686ace877a092c3032d |
institution | Directory Open Access Journal |
issn | 2039-4705 2039-4713 |
language | English |
last_indexed | 2024-03-11T02:16:05Z |
publishDate | 2023-05-01 |
publisher | MDPI AG |
record_format | Article |
series | Journal of Xenobiotics |
spelling | doaj.art-170c10edb2494686ace877a092c3032d2023-11-18T11:09:54ZengMDPI AGJournal of Xenobiotics2039-47052039-47132023-05-0113221823610.3390/jox13020017Systematic Review of Safety of Selective Androgen Receptor Modulators in Healthy Adults: Implications for Recreational UsersJonathan D. Vignali0Kevin C. Pak1Holly R. Beverley2Jesse P. DeLuca3John W. Downs4Adrian T. Kress5Brett W. Sadowski6Daniel J. Selig7Behavioral Biology Branch, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USADepartment of Gastroenterology, Naval Medical Center San Diego, San Diego, CA 92134, USAGorgas Memorial Library, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USAClinical Pharmacology Fellowship, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USADepartment of Toxicology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USAClinical Pharmacology Fellowship, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USADepartment of Gastroenterology, Naval Medical Center San Diego, San Diego, CA 92134, USAClinical Pharmacology Fellowship, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USASelective Androgen Receptor Modulators (SARMs) are not FDA approved, and obtaining SARMs for personal use is illegal. Nevertheless, SARM use is increasingly popular amongst recreational athletes. Recent case reports of drug-induced liver injury (DILI) and tendon rupture raise serious concerns for the safety of recreational SARM users. On 10 November 2022 PubMed, Scopus, Web of Science, and ClinicalTrials.gov were searched for studies that reported safety data of SARMs. A multi-tiered screening approach was utilized, and any study or case report of generally healthy individuals exposed to any SARM was included. Thirty-three studies were included in the review with 15 case reports or case series and 18 clinical trials (total patients N = 2136 patients, exposed to SARM N = 1447). There were case reports of drug-induced liver injury (DILI) (N = 15), Achilles tendon rupture (N = 1), rhabdomyolysis (N = 1), and mild reversible liver enzyme elevation (N = 1). Elevated alanine aminotransferase (ALT) was commonly reported in clinical trials in patients exposed to SARM (mean 7.1% across trials). Two individuals exposed to GSK2881078 in a clinical trial were reported to have rhabdomyolysis. Recreational SARM use should be strongly discouraged, and the risks of DILI, rhabdomyolysis, and tendon rupture should be emphasized. However, despite warnings, if a patient refuses to discontinue SARM use, ALT monitoring or dose reduction may improve early detection and prevention of DILI.https://www.mdpi.com/2039-4713/13/2/17athletedrug-induced liver injurydrug safetyrecreationselective androgen receptor modulatortendon rupture |
spellingShingle | Jonathan D. Vignali Kevin C. Pak Holly R. Beverley Jesse P. DeLuca John W. Downs Adrian T. Kress Brett W. Sadowski Daniel J. Selig Systematic Review of Safety of Selective Androgen Receptor Modulators in Healthy Adults: Implications for Recreational Users Journal of Xenobiotics athlete drug-induced liver injury drug safety recreation selective androgen receptor modulator tendon rupture |
title | Systematic Review of Safety of Selective Androgen Receptor Modulators in Healthy Adults: Implications for Recreational Users |
title_full | Systematic Review of Safety of Selective Androgen Receptor Modulators in Healthy Adults: Implications for Recreational Users |
title_fullStr | Systematic Review of Safety of Selective Androgen Receptor Modulators in Healthy Adults: Implications for Recreational Users |
title_full_unstemmed | Systematic Review of Safety of Selective Androgen Receptor Modulators in Healthy Adults: Implications for Recreational Users |
title_short | Systematic Review of Safety of Selective Androgen Receptor Modulators in Healthy Adults: Implications for Recreational Users |
title_sort | systematic review of safety of selective androgen receptor modulators in healthy adults implications for recreational users |
topic | athlete drug-induced liver injury drug safety recreation selective androgen receptor modulator tendon rupture |
url | https://www.mdpi.com/2039-4713/13/2/17 |
work_keys_str_mv | AT jonathandvignali systematicreviewofsafetyofselectiveandrogenreceptormodulatorsinhealthyadultsimplicationsforrecreationalusers AT kevincpak systematicreviewofsafetyofselectiveandrogenreceptormodulatorsinhealthyadultsimplicationsforrecreationalusers AT hollyrbeverley systematicreviewofsafetyofselectiveandrogenreceptormodulatorsinhealthyadultsimplicationsforrecreationalusers AT jessepdeluca systematicreviewofsafetyofselectiveandrogenreceptormodulatorsinhealthyadultsimplicationsforrecreationalusers AT johnwdowns systematicreviewofsafetyofselectiveandrogenreceptormodulatorsinhealthyadultsimplicationsforrecreationalusers AT adriantkress systematicreviewofsafetyofselectiveandrogenreceptormodulatorsinhealthyadultsimplicationsforrecreationalusers AT brettwsadowski systematicreviewofsafetyofselectiveandrogenreceptormodulatorsinhealthyadultsimplicationsforrecreationalusers AT danieljselig systematicreviewofsafetyofselectiveandrogenreceptormodulatorsinhealthyadultsimplicationsforrecreationalusers |